Article
A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii.
International journal of antimicrobial agents - 1 Jun 2017
Dahdouh Elias, Gómez-Gil Rosa, Sanz Sonia, González-Zorn Bruno, Daoud Ziad, Mingorance Jesús, Suárez Monica
Abstract excerpt
Acinetobacter baumannii is a highly versatile nosocomial pathogen. Multidrug resistance among A. baumannii isolates led to the use of colistin, subsequently giving rise to colistin-resistant strains. In this study, the genetic and phenotypic profiles of two colistin-resistant A. baumannii isolates were investigated. Two A. baumannii isolates were obtained from Patient 1 (C071 and C440) and three isolates were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
